U.S. Markets for Stroke Management, August 2015

The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke.  Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke.  Topics covered in this report include:

• diagnostic, interventional, and pharmaceutical stroke-related products;
• procedure and market forecasts for the years 2014 to 2019;
• key factors influencing the growth of individual product markets;
• estimated market shares and sales among major U.S. suppliers;
• major supplier product portfolio analysis in individual product markets; and,
• emerging technology that could potentially change the way stroke is diagnosed and treated, which could potentially change how product markets develop.

Over the forecast period covered in this report (2014 through 2019), the estimated value of the U.S. market for stroke management systems (not including pharmaceutical agents) is expected to grow by approximately $284.2 million at compound annual growth rate (CAGR) of 5.1%; for the overall stroke management market; diagnostic imaging products are forecasted to grow at a CAGR of 3.6%, while surgical and endovascular products will grow at a CAGR of 5.4%.